Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Free Cash Flow (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Free Cash Flow for 17 consecutive years, with -$6.9 million as the latest value for Q1 2026.

  • Quarterly Free Cash Flow rose 37.48% to -$6.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$45.3 million through Mar 2026, down 27.48% year-over-year, with the annual reading at -$49.5 million for FY2025, 66.28% down from the prior year.
  • Free Cash Flow for Q1 2026 was -$6.9 million at Achieve Life Sciences, up from -$18.0 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$4.4 million in Q4 2023, with the low at -$18.0 million in Q4 2025.
  • Average Free Cash Flow over 5 years is -$8.7 million, with a median of -$8.3 million recorded in 2022.
  • The sharpest move saw Free Cash Flow plummeted 113.55% in 2022, then soared 60.78% in 2023.
  • Achieve Life Sciences' Free Cash Flow stood at -$11.1 million in 2022, then soared by 60.78% to -$4.4 million in 2023, then crashed by 110.27% to -$9.2 million in 2024, then plummeted by 95.89% to -$18.0 million in 2025, then skyrocketed by 61.49% to -$6.9 million in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Free Cash Flow are -$6.9 million (Q1 2026), -$18.0 million (Q4 2025), and -$11.3 million (Q3 2025).